Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy

Seminars in Cancer Biology
Naila RabbaniP J Thornalley

Abstract

Glyoxalase 1 (Glo1) is part of the glyoxalase system in the cytoplasm of all human cells. It catalyses the glutathione-dependent removal of the endogenous reactive dicarbonyl metabolite, methylglyoxal (MG). MG is formed mainly as a side product of anaerobic glycolysis. It modifies protein and DNA to form mainly hydroimidazolone MG-H1 and imidazopurinone MGdG adducts, respectively. Abnormal accumulation of MG, dicarbonyl stress, increases adduct levels which may induce apoptosis and replication catastrophe. In the non-malignant state, Glo1 is a tumour suppressor protein and small molecule inducers of Glo1 expression may find use in cancer prevention. Increased Glo1 expression is permissive for growth of tumours with high glycolytic activity and is thereby a biomarker of tumour growth. High Glo1 expression is a cause of multi-drug resistance. It is produced by over-activation of the Nrf2 pathway and GLO1 amplification. Glo1 inhibitors are antitumour agents, inducing apoptosis and necrosis, and anoikis. Tumour stem cells and tumours with high flux of MG formation and Glo1 expression are sensitive to Glo1 inhibitor therapy. It is likely that MG-induced cell death contributes to the mechanism of action of current antitumour agents. ...Continue Reading

Citations

Feb 1, 2018·International Journal of Molecular Sciences·Cinzia Antognelli, Vincenzo Nicola Talesa
Dec 3, 2017·Molecular & Cellular Proteomics : MCP·Rupert L MayerChristopher Gerner
Dec 8, 2019·Nature Communications·Alba LuengoMatthew G Vander Heiden
Aug 17, 2020·ELife·Chaitanya A KulkarniPaul S Brookes
Aug 7, 2020·Cancers·Pedro Flores-VillanuevaYong Li
Sep 3, 2020·Nutrients·Mirela IbrahimovicLaura A Kresty
Jul 30, 2020·International Journal of Molecular Sciences·Betina SchmidtEliane Fialho
Oct 7, 2020·Antioxidants·Jakob MorgensternThomas Fleming
Jun 27, 2020·Methods : a Companion to Methods in Enzymology·Alejandro Gugliucci, Russell Caccavello
Nov 24, 2019·Trends in Endocrinology and Metabolism : TEM·Rasmus Kold-Christensen, Mogens Johannsen
Jan 14, 2020·Redox Biology·Panagis PolykretisLucia Banci
Mar 26, 2021·BMJ Open Diabetes Research & Care·Ninon FoussardVincent Rigalleau
May 1, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Dan TangHong Nie
Sep 8, 2018·Chemical Reviews·Allie Y ChenSeth M Cohen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.